P28 Rezafungin efficacy and safety in immunocompromised patients: sub-analyses of the Phase 3 trial in treatment of candidaemia and invasive candidiasis

BACKGROUND: Rezafungin (RZF) once weekly (QWk) is a next-generation echinocandin in development for treatment of candidaemia and invasive candidiasis (IC) and for prevention of invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp. in BMT. OBJECTIVES: The Phase 3 ReSTORE treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandison, Taylor, Ramos-Martinez, Antonio, Kim, Young Keun, Chai, Louis, Slavin, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266150/
http://dx.doi.org/10.1093/jacamr/dlad066.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266150/
http://dx.doi.org/10.1093/jacamr/dlad066.032

Ejemplares similares